Authors:
Proctor, SJ
Taylor, PRA
Angus, B
Wood, K
Lennard, AL
Lucraft, H
Carey, PJ
Stark, A
Iqbal, A
Haynes, A
Russel, N
Leonard, RCF
Culligan, D
Conn, J
Jackson, GH
Citation: Sj. Proctor et al., High-dose ifosfamide in combination with etoposide and epirubicin (IVE) inthe treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy, EUR J HAEMA, 66, 2001, pp. 28-32
Authors:
Thomas, MJ
Irving, JAE
Lennard, AL
Proctor, SJ
Taylor, PRA
Citation: Mj. Thomas et al., Validation of the Hasford score in a demographic study in chronic granulocytic leukaemia, J CLIN PATH, 54(6), 2001, pp. 491-493
Authors:
Jackson, GH
Angus, B
Carey, PJ
Finney, RD
Galloway, MJ
Goff, DK
Haynes, A
Lennard, AL
Leonard, RCF
McQuaker, IG
Proctor, SJ
Russell, N
Windebank, K
Taylor, PRA
Citation: Gh. Jackson et al., High dose ifosfamide in combination with etoposide and epirubicin followedby autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy, LEUK LYMPH, 37(5-6), 2000, pp. 561-570
Citation: Hh. Lucraft et al., Comments on: Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease, Tsang, et al. Eur J Cancer 1999, 35, 73-78, EUR J CANC, 35(10), 1999, pp. 1551-1551